Stay updated with breaking news from Lunit Scope. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9 studies at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress, to be held in Madrid, Spain, from October 20-24.
On August 24, 2023, the National Labor Relations Board (the “Board”) issued a final rule (the “2023 final rule”) amending the federal regulations that govern representation election...
U.S. Court of Appeals for the D.C. Circuit partially reversed and partially upheld District Court decision that enjoined five rules promulgated by National Labor Relations Board in 2019 by the Trump-era Board to modify Board’s representation election procedures.
On January 17, 2023, the U.S. Court of Appeals for the D.C. Circuit partially reversed and partially upheld a District Court decision that enjoined five rules promulgated by the...
An AI-based test developed by South Korean biotech Lunit may improve identification of best responders to immunotherapy when used alongside PD-L1 testing.